FMT
AKRO

First Mercantile Trust’s Akero Therapeutics AKRO Stock Holding History

First Mercantile Trust’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$45K Buy
+2,030
New +$46K 0.01% 782
2021
Q1 		– Sell
-300
Closed -$8K – 844
2020
Q4 		$8K Hold
300
– – ﹤0.01% 848
2020
Q3 		$9K Buy
+300
New +$10.5K ﹤0.01% 847

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Mercantile Trust's AKRO Position: Q3 2021 in Review

First Mercantile Trust opened a new position in Akero Therapeutics (AKRO) in Q3 2021: 2,030 shares worth $45K. The stake represents 0.01% of the portfolio and ranks #782 among its holdings. This is a return to the name: First Mercantile Trust previously reported a position in AKRO as recently as Q4 2020.

First Mercantile Trust first reported a position in AKRO in Q3 2020 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold AKRO as of Q3 2021.

  • First Mercantile Trust held 2,030 shares of Akero Therapeutics worth $45K as of Q3 2021.
  • Akero Therapeutics was a new First Mercantile Trust position in Q3 2021.
  • Akero Therapeutics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #782 holding.
  • First Mercantile Trust first reported a position in Akero Therapeutics in Q3 2020 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Akero Therapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.